Search results
The U.S. Government Plans To Reclassify Marijuana From A Schedule I To Schedule III Drug. Here Are...
Forbes· 2 days agoMarijuana would still be federally illegal even if reclassified as a Schedule III drug, but a change...
Life-saving overdose drug to be given without prescription
BBC via Yahoo News· 6 hours agoThere will also be improved and more formalised training and accreditation for drug workers. Clare...
Louisiana moves to make abortion pills ‘controlled dangerous substances’
Washington Post via Yahoo News· 5 hours agoLouisiana could become the first state in the country to categorize mifepristone and misoprostol -...
Public officials seek greater oversight of Rx drug middlemen
The Danville Commercial-News· 5 days agoOften referred to as pharmaceutical “middlemen,” PBMs act as third-party intermediaries who...
Still much unknown on how marijuana policies would change in states under Biden plan
Michigan Advance via Yahoo News· 20 hours agoU.S. Attorney General Merrick Garland has proposed loosening the illegal status of marijuana at the...
RxDC reporting: June 3 deadline looms - with David Mordo, Part 1
BenefitsPRO· 15 hours agoIn this episode of ShiftShapers, host David Saltzman invites David Mordo, Senior Compliance Officer...
Letters: Insurance middlemen harm those with chronic illness
New Orleans Times-Picayune· 7 days agoAct 579 requires certain health insurance issuers to notify enrollees and prospective enrollees that...
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 4 days agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 15 hours agoThe regulatory body notified the company that due to administrative constraints, it would not be...
Maine opioid settlement money is being directed toward policing
Bangor Daily News· 17 hours agoThe money is coming from settlements that capped years of litigation against prescription drug...